Expert Workshop on Monoclonal Antibodies against AMR Pathogens
Begin
End
Location
The Paul-Ehrlich-Institut, on behalf of the COMBINE project, is organising a two-day, free, virtual workshop to discuss recurring challenges and possible mitigation strategies in the development of monoclonal antibodies (mAbs) against AMR pathogens. The workshop is open to industry, academia, research institutes, regulatory and public health bodies.
The COMBINE project is part of the IMI AMR Accelerator. COMBINE wants to address capability building questions regarding the optimization of preclinical and clinical studies in the development of antibiotics, vaccines and other therapies to tackle AMR pathogens